Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Respiratory
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Quitting Smoking Adds Years to Life, Study Confirms
October 2025
A landmark 32.5-year follow-up of a smoking cessation intervention showed enduring reductions in respiratory mortality among U.S. adults who received targeted support to quit smoking.
Read more
30 Oct 2025
Quitting Smoking Adds Years to Life, Study Confirms
A landmark 32.5-year follow-up of a smoking cessation intervention showed enduring reductions in respiratory mortality among U.S. adults who received targeted support to quit smoking.
28 Oct 2025
Why Stubborn Lung Infections Persist Despite Therapy
Stubborn lung infection can evolve within patients and develop traits that help it persist over time.
25 Oct 2025
GLP-1 Therapy Improves Survival in Diabetes and Sleep Apnea
Patients with type 2 diabetes and obstructive sleep apnea experienced significantly greater survival benefits from GLP-1 receptor agonist therapy than those without sleep apnea.
24 Oct 2025
CHEST 2025: Improved Cardiac Function with Treprostinil in ASCENT Trial
Inhaled treprostinil treatment improved cardiac effort and physiological function in patients with pulmonary hypertension–interstitial lung disease.
23 Oct 2025
CHEST 2025: GLP-1 Receptor Agonists Cut Right Heart Failure Risk
GLP-1 receptor agonists significantly reduced the risk of right heart failure in patients with pulmonary arterial hypertension compared with SGLT2-inhibitors.
23 Oct 2025
Nasal Irrigation Rivals Sputum Testing in Cystic Fibrosis
Nasal irrigation could provide a practical, non-invasive alternative for monitoring airway microbiology in people with cystic fibrosis.
22 Oct 2025
CHEST 2025: Ensifentrine Boosts Quality of Life in COPD
Ensifentrine improved symptoms, dyspnea, and quality of life in stable COPD without exacerbations in ENHANCE trials.
21 Oct 2025
CHEST 2025: New Algorithm Enhances AATD Diagnosis Accuracy
Alpha-1 antitrypsin deficiency (AATD) remains a frequently underdiagnosed condition that predisposes individuals to chronic lung and liver diseases.
Loading posts...
1
2
3
…
24
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View